COOPERATIVE DES PHARMACIENS DU SUD : revenue, balance sheet and financial ratios

COOPERATIVE DES PHARMACIENS DU SUD is a French company founded 11 years ago, specialized in the sector Autres activités de soutien aux entreprises n.c.a.. Based in PERPIGNAN (66100), this company of category PME shows in 2024 a revenue of 878 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - COOPERATIVE DES PHARMACIENS DU SUD (SIREN 803925940)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 877 984 € 827 325 € 1 216 999 € 1 138 525 € 1 002 416 € 765 024 € 649 780 € 795 183 € 820 172 €
Net income 551 773 € 471 959 € 633 350 € 484 857 € 379 871 € 392 185 € 270 172 € 193 350 € 153 112 €
EBITDA 339 294 € 311 992 € 532 327 € 417 011 € 370 655 € 389 268 € 260 868 € 193 897 € 165 508 €
Net margin 62.8% 57.0% 52.0% 42.6% 37.9% 51.3% 41.6% 24.3% 18.7%

Revenue and income statement

In 2024, COOPERATIVE DES PHARMACIENS DU SUD achieves revenue of 878 k€. Revenue is growing positively over 9 years (CAGR: +0.9%). Vs 2023: +6%. After deducting consumption (234 k€), gross margin stands at 644 k€, i.e. a rate of 73%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 339 k€, representing 38.6% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 552 k€, i.e. 62.8% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

877 984 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

643 537 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

339 294 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

514 419 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

551 773 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

38.6%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 90%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 43.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

90.275%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

42.978%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

15.3%

Solvency indicators evolution
COOPERATIVE DES PHARMACIENS DU SUD

Sector positioning

Debt ratio
0.0 2024
2022
2023
2024
Q1: 0.0
Med: 5.61
Q3: 47.03
Excellent

In 2024, the debt ratio of COOPERATIVE DES PHARMACIE... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
90.28% 2024
2022
2023
2024
Q1: 6.21%
Med: 32.46%
Q3: 67.88%
Excellent

In 2024, the financial autonomy of COOPERATIVE DES PHARMACIE... (90.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.29 years
Excellent

In 2024, the repayment capacity of COOPERATIVE DES PHARMACIE... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1026.47. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1026.469

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
COOPERATIVE DES PHARMACIENS DU SUD

Sector positioning

Liquidity ratio
1026.47 2024
2022
2023
2024
Q1: 120.11
Med: 218.14
Q3: 571.7
Excellent

In 2024, the liquidity ratio of COOPERATIVE DES PHARMACIE... (1026.47) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.0x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 1.61x
Average

In 2024, the interest coverage of COOPERATIVE DES PHARMACIE... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 146 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 35 days. The gap of 111 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 5 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 165 days of revenue, i.e. 402 k€ to permanently finance. Over 2016-2024, WCR increased by +72%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

401 590 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

146 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

35 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

5 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

165 j

WCR and payment terms evolution
COOPERATIVE DES PHARMACIENS DU SUD

Positioning of COOPERATIVE DES PHARMACIENS DU SUD in its sector

Comparison with sector Autres activités de soutien aux entreprises n.c.a.

Valuation estimate

Based on 131 transactions of similar company sales (all years), the value of COOPERATIVE DES PHARMACIENS DU SUD is estimated at 1 282 534 € (range 403 411€ - 2 670 090€). With an EBITDA of 339 294€, the sector multiple of 4.8x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
131 transactions
403k€ 1282k€ 2670k€
1 282 534 € Range: 403 411€ - 2 670 090€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
339 294 € × 4.8x
Estimation 1 645 511 €
494 103€ - 2 830 779€
Revenue Multiple 30%
877 984 € × 0.36x
Estimation 313 100 €
156 378€ - 591 816€
Net Income Multiple 20%
551 773 € × 3.3x
Estimation 1 829 243 €
547 236€ - 5 385 778€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 131 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Autres activités de soutien aux entreprises n.c.a.)

Compare COOPERATIVE DES PHARMACIENS DU SUD with other companies in the same sector:

Voir toutes les statistiques du secteur Autres activités de soutien aux entreprises n.c.a.

Frequently asked questions about COOPERATIVE DES PHARMACIENS DU SUD

What is the revenue of COOPERATIVE DES PHARMACIENS DU SUD ?

The revenue of COOPERATIVE DES PHARMACIENS DU SUD in 2024 is 878 k€.

Is COOPERATIVE DES PHARMACIENS DU SUD profitable?

Yes, COOPERATIVE DES PHARMACIENS DU SUD generated a net profit of 552 k€ in 2024.

Where is the headquarters of COOPERATIVE DES PHARMACIENS DU SUD ?

The headquarters of COOPERATIVE DES PHARMACIENS DU SUD is located in PERPIGNAN (66100), in the department Pyrenees-Orientales.

Where to find the tax return of COOPERATIVE DES PHARMACIENS DU SUD ?

The tax return of COOPERATIVE DES PHARMACIENS DU SUD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does COOPERATIVE DES PHARMACIENS DU SUD operate?

COOPERATIVE DES PHARMACIENS DU SUD operates in the sector Autres activités de soutien aux entreprises n.c.a. (NAF code 82.99Z). See the 'Sector positioning' section above to compare the company with its competitors.